Nick Marchant is currently the Vice President, Value & Access Strategy Head for Rare Diseases and Internal Medicine at Pfizer. Their experience at Pfizer includes various leadership roles in health impact and market access, notably serving as Vice President for teams focused on Eliquis and Vyndaqel. They began their career as a Health Economist at the Office of Health Economics and also held a Health Economics Manager position at AstraZeneca. Previously, they worked as Global Health Outcomes Director Team Leader at GSK and in multiple roles at Pfizer UK.
This person is not in the org chart
This person is not in any teams
This person is not in any offices